File Download

There are no files associated with this item.

Supplementary

Article: A phase 1b trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in patients with advanced solid tumor

TitleA phase 1b trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in patients with advanced solid tumor
Authors
Issue Date2016
Citation
Invest New Drugs , 2016, v. 34 n. 1, p. 204-211 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/234690

 

DC FieldValueLanguage
dc.contributor.authorChiu, WYJ-
dc.contributor.authorHotte, SJ-
dc.contributor.authorKollmannsberger, CK-
dc.contributor.authorRenouf, DJ-
dc.contributor.authorCescon, DW-
dc.contributor.authorHedley, D-
dc.contributor.authorChow, S-
dc.contributor.authorMoscow, J-
dc.contributor.authorPerry, M-
dc.contributor.authorDiaz-Padilla, I-
dc.contributor.authorTan, D-
dc.contributor.authorHirte, H-
dc.contributor.authorMcWhirter, E-
dc.contributor.authorChen, H-
dc.contributor.authorSiu, LL-
dc.contributor.authorBedard, PL-
dc.date.accessioned2016-10-14T13:48:38Z-
dc.date.available2016-10-14T13:48:38Z-
dc.date.issued2016-
dc.identifier.citationInvest New Drugs , 2016, v. 34 n. 1, p. 204-211-
dc.identifier.urihttp://hdl.handle.net/10722/234690-
dc.languageeng-
dc.relation.ispartofInvest New Drugs -
dc.titleA phase 1b trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in patients with advanced solid tumor-
dc.typeArticle-
dc.identifier.emailChiu, WYJ: jwychiu@hku.hk-
dc.identifier.authorityChiu, WYJ=rp01917-
dc.identifier.hkuros267915-
dc.identifier.volume34-
dc.identifier.issue1-
dc.identifier.spage204-
dc.identifier.epage211-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats